AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease

Contributed by: ACCESS Newswire

Logo

ACCESS Newswire logo

Images

ACCESS Newswire associated0
ACCESS Newswire associated1

Tags

Biotechnology
Northway Biotech
Partnerships

More Like This

ACCESS Newswire associated0

Micreos Pharmaceuticals Partners With Biologics CDMO Northway Biotech for Its Engineered Endolysin Therapeutic Manufacturing Program

ACCESSWIRE associated0

Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment

PR Newswire associated0

GBI Biomanufacturing and Allterum Therapeutics Announce Strategic Collaboration to Manufacture Therapeutic Antibody for Clinical Trials

EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics

Business Wire logo

Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009)

EQT Life Sciences leads USD 75 million Series B in Atalanta Therapeutics, a biotech firm developing treatments for epilepsy and Huntington's disease

Beactica Therapeutics announces collaboration with the National Center for Advancing Translational Sciences

AscellaHealth Demonstrates Leadership in Realizing the Full Potential of Novel Therapies and Medicinal Products at Advanced Therapies Integrates North 2025